Product Program year 2025 Source: CMS Open Payments

ACell

Device Recon-Skin And Wound

PDI 00386190001295

Open in the dashboard

General payments

$276,869

900 payments

Research payments

$0

0 payments

Through program year 2025, $276,869 in general payments and $0 in research payments were reported against ACell (Recon-Skin And Wound).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $50,000 1
2024 General $175,013 684
2023 General $38,100 117
2022 General $13,755 98

Breakdown

Who paid General payments · program years 2022–2025
  1. Integra LifeSciences Corporation $276,869 900 payments
Top recipients General payments · program year 2024
  1. Peter Muscarella Surgery · Portsmouth, OH $5,161 3% · 1 payment
  2. Harry Sun Surgery · Livingston, NJ $2,551 1% · 4 payments
  3. Cherreen Tawancy Podiatrist, Foot & Ankle Surgery · Newark, OH $2,419 1% · 2 payments
  4. Robert Schulz Plastic and Reconstructive Surgery · Honolulu, HI $2,119 1% · 1 payment
  5. Arash Keyhani Vascular Surgery · Houston, TX $2,067 1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Surgery $43,411 25% · 69 practitioners
  2. Podiatrist, Foot & Ankle Surgery Podiatrist $28,823 17% · 79 practitioners
  3. Plastic Surgery $12,984 7% · 29 practitioners
  4. Podiatrist $11,714 7% · 35 practitioners
  5. Plastic and Reconstructive Surgery Surgery $8,572 5% · 14 practitioners

The top 5 of 46 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $23,445 13% · 56 recipients
  2. New Jersey $20,525 12% · 41 recipients
  3. Massachusetts $14,753 8% · 24 recipients
  4. Florida $12,216 7% · 42 recipients
  5. New York $11,529 7% · 19 recipients

The top 5 of 42 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

900 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record